News
8/24/2010
GaBio to Honor Bernie and Billi Marcus for Advancing Medical Innovation
Atlanta, GA. (August 18, 2010... Read More
8/12/2010
Read More
8/9/2010
ATHENS, GA, August 9, 2010 – University System of Georgia Chancellor Erroll B. Davis Jr., Medical College of Georgia President Ricardo Azziz and University of Georgia President Michael F. Adams will address reporter... Read More
8/5/2010
Read More
8/5/2010
Yerkes-based research is critical to determining w... Read More
7/29/2010
ATLANTA, Ga, July 29, 2010 – Governor Sonny Perdue announced today the following executive appointments. Brief biographies are provided below:
Georgia Medical Center Authority
... Read More
7/22/2010
SMYRNA, Ga., July 22 /PRNewswire-FirstCall/ -- Dr. Harriet L. Robinson, Chief Scientific Officer at GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, discussed the Company's pursuit of a vaccine durin... Read More
7/21/2010
Atlanta, GA (July 21, 2010) - Southeast BIO (SEBIO) announced that it has selected ten semifinalists in its fourth annual BIO/Plan Competition. Launched in 2007, the BIO/Plan Competition is a program developed to promote the creation of new life science companies based in the ... Read More
7/21/2010
ATHENS, Ga.- The University of Georgia has been awarded federal stimulus funding to launch an innovative new program that will help meet the workforce needs of Georgia’s growing biotechnology industry.
The three-year $700,000 grant from the National Science Foundation will create a n... Read More
7/20/2010
LAWRENCEVILLE – Gwinnett Technical College bioscience student Jenny Hedges knows how to make an impression while completing an internship. Hedges applied the skills she learned in the classroom and manufactured a vaccine to treat fish for enteric redmouth disease, or ERM, as part of... Read More
7/9/2010
ATLANTA, Georgia – July 9, 2010 – InVasc Therapeutics, Inc. today has had a initial closing of $3,150,000 in its first institutional financing. The investment was led by Trois I Investments Industriels Internationaux S.A., headquartered in Luxembourg.
“We welco... Read More
6/29/2010
ATLANTA, Jun 29, 2010 (GlobeNewswire via COMTEX News Network) -- Alimera Sciences, Inc., (Nasdaq:ALIM), ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, has submitted a New Drug A... Read More
6/14/2010
ATLANTA, June 14 /PRNewswire/ -- Lt. Governor Casey Cagle today joined Georgia Bio, the Georgia Research Alliance, the Metro Atlanta Chamber and the Innovation Crescent business community in announcing the launch of the Georgia Bioscience Commercialization Center (GBCC), which will ... Read More
6/11/2010
(Lawrenceville, Ga., June 11, 2010) – The U.S. Economic Development Administration has awarded the Georgia Bioscience Joint Development Authority (GBJDA) a $50,000 short-term planning matching grant to conduct an economic development study that will assist in the creation and implem... Read More
6/8/2010
Atlanta, Ga. (June 8, 2010) – In advance of the July 20 gubernatorial primary elections, Georgia Bio asked the seven Democratic and seven Republican candidates to submit written answers to three questions of critical significance to Georgia’s life sciences industry and the state’s f... Read More
6/1/2010
Atlanta, GA – The CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients) trial met its primary efficacy endpoint with a 30% reduction in heart failure hospitalization rates at 6 months (p<0.001) in heart failure patients whose treatment wa... Read More
5/25/2010
ATLANTA, GA (May 25, 2010) – Five Georgia state technical colleges have formed a partnership to recruit and train workers for the state’s bioscience industry. Supported by Athens, Atlanta, Augusta, Gwinnett, and Valdosta Technical Colleges, the Georgia Bioscience Technology In... Read More
5/21/2010
WASHINGTON, DC (May 21, 2010) – The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development pr... Read More
5/19/2010
ATLANTA, May 19, 2010 —The Georgia Department of Economic Development announced today that Georgia-based Animal Health & Sciences is opening a manufacturing facility in Thomaston, Georgia in Upson County. This project represents the creation of 100 new jobs, and a $9.1 mil... Read More
5/19/2010
ATLANTA, Georgia – May 19, 2010 – InVasc Therapeutics, Inc. today announced that it has been awarded two Small Business Innovations Research (SBIR) Phase 1 grants by the National Institutes of Health. One grant is to continue research and development of small molecule drugs fo... Read More
5/18/2010
ATLANTA (May 18, 2010) – Georgia Bio late Monday decided to cancel Democratic and Republican gubernatorial forums at Kennesaw State University based on a lack of interest among most of the primary candidates to attend and discuss life sciences related issues.
“We sinc... Read More
5/17/2010
SMYRNA, Ga., May 17 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVXD), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, today announced that its Chief Scientific Officer, Harriet L. Robinson, Ph.D., will speak at a symposiu... Read More
5/13/2010
ATLANTA, GA (May 13, 2010) – The Georgia Science Teachers Association (GSTA) and Georgia Bio announce a first-ever partnership to highlight biotechnology education at the 2011 GSTA Annual Conference. The conference, scheduled for February 17-19, 2011, at the Hyatt Regency, Atl... Read More
5/13/2010
ATLANTA (May 13, 2010) – Life sciences economic development, science education and the impact of federal health care reform will be the major topics of discussion at Democratic and Republican gubernatorial candidate forums in May organized by Georgia Bio (GaBio) and hosted by Kennes... Read More
5/9/2010
Atlanta – May 7, 2010. CardioMEMS, Inc., a medical technology company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced the completion of a $37.9M financing. The financing provides th... Read More
5/5/2010
ATLANTA, May 5 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVXD), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, today announced its financial results for the three months ended March 31, 2010.
GeoVax repor... Read More
5/4/2010
ATHENS, GA – Two University of Georgia animal science researchers introduced to the world 13 pigs that may hold the key to new therapies to treat human diseases, including diabetes. Announced this week, the discovery marks the first time pluripotent stem cells, or cells that can tur... Read More
5/4/2010
ATLANTA, GA (PRWEB) – Aderans Research Institute Inc. (ARI) said today it has expanded its clinical trials on hair regeneration by an additional seven cities in the United States. Las Vegas, NV; Los Angeles, CA; and N... Read More
5/3/2010
ATLANTA, GA (May 3, 2010) – Georgia Bio congratulates Anne Wang, a junior at George Walton Comprehensive High School in Cobb County. Ms. Wang was awarded the Georgia Bio Science Fair Award at the Georgia Science and Engineering Fair held in Athens, Georg... Read More
5/3/2010
ATLANTA, Ga. (May 3, 2010) – Georgia Bio, the Georgia Research Alliance, the State of Georgia, the Metro Atlanta Chamber and the Innovation Crescent business community have formed a partnership to create the Georgia Bioscience Commercialization Center (GBCC), which will act as a sta... Read More
4/29/2010
SEATTLE, April 29, 2010 /PRNewswire via COMTEX/ --Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) has approved PROVENGE(R) (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptom... Read More
4/23/2010
ATLANTA, Apr 23, 2010 (GlobeNewswire via COMTEX News Network) -- Alimera Sciences, Inc. (Nasdaq:ALIM), ("Alimera") today announced that it priced its initial public offering of 6,550,000 shares of common stock at a price to the public of $11.00 per share on Wednesday, April 21... Read More
4/22/2010
When the Health Care Reform Bill was passed on March 23, 2010 it included a Tax Credit or Cash Grant for qualifying small businesses developing therapeutics, molecular diagnostic... Read More
4/16/2010
ATLANTA, April 16 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, today announced it will implement a 1-for-50 reverse stock split effective following the close of busines... Read More
4/15/2010
Atlanta, GA –4/15/2010 – Peachtree BioResearch Solutions, Inc., a business specializing in contract clinical research services, received national certification as a Women’s Business Enterprise by the Greater Women’s Business Council, a regional certifying partner of the Women’s Busi... Read More
4/12/2010
ATLANTA (April 12, 2010) – Life sciences economic development, science education in k-12 schools and the impact of federal health care reform will be the major topics of discussion at Democratic and Republican gubernatorial candidate forums in May organized by Georgia Bio (GaBio) an... Read More
4/12/2010
RALEIGH, N.C., April 12 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceuticalcompany focused on pediatric medicine, announced today that an investment group led by Jason Wild of JW Asset Management, LLC and Edward Schutter has acquired the company. Jason Wild has been na... Read More
4/8/2010
Atlanta, Ga. (April 8, 2010) – Representatives of five top law firms will participate in a panel session hosted by Georgia Bio (GaBio) Thursday, April 29, from 4 pm to 6 pm, to translate the landmark federal health care reform legislation.
This unique event, to be hel... Read More
4/1/2010
SMYRNA, GA GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the U.... Read More
3/30/2010
Augusta, Ga. – The MCGHealth Bone Marrow and Stem Cell Transplant Program was recently named a network transplant center by the National Marrow Donor Program. With this status comes the approval to transplant using unrelated donors from the national registry.
Transpla... Read More
3/29/2010
WASHINGTON, DC – United States Surgeon General Regina Benjamin, M.D., will deliver a keynote address at the 2010 BIO Inte... Read More
3/29/2010
Atlanta, Georgia – March 29, 2010 -- The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprieta... Read More
3/25/2010
Aderans Research Institute Inc. (ARI) announced it acquired key technology assets from Regenerative Medicine Assets Limited (formerly Intercytex Group plc), a leading UK hair regeneration company. By acquiring the scientific assets of one of its chief competitors, ARI has further solidified its ... Read More
3/24/2010
CHARLOTTE, NC – PRNewswire-HISPANIC PR WIRE – The National Hispanic Entrepreneurs' Organization (NHEO) announces that Mr. Juan Sepulveda, appointed in 2009 by Secretary of Education Arne Duncan as Director for the White House Initiative on Educational... Read More
3/24/2010
ATLANTA, /PRNewswire via COMTEX/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has withdrawn ... Read More
3/22/2010
Washington, D.C. (March 22, 2010) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement after passage of “The Patient Protection and Affordable Care Act of 2009” by the U.S. House of Representatives:
... Read More
3/22/2010
For Immediate Release:
Miami, FL. March 22, 2010 – Diffusion Pharmaceuticals LLC is the winner of the 1st Annual Perfect Pitch- Biotech Investment Challenge. The winner was announced March 16, 2010 at a special awards ceremony attended by over 150 delegates and guests... Read More
3/19/2010
ATLANTA, PRNewswire via COMTE... Read More
3/14/2010
ATLANTA, GA – Iverson Genetic Diagnostics, Inc. today announced that they will conduct a WARFARIN clinical study to assess the efficacy of gene-based testin... Read More
3/11/2010
ATLANTA, GA (March 11, 2010) – Georgia Bio has been invited to present at the 2nd Annual Innovation in Education Conference at the Georgia International Convention Center on
March 12, 2010. The conference, convened by Lt. Governor Casey Cagle, brings together business and education to pose th... Read More
3/9/2010
ATLANTA, GA (March 9, 2010) – Georgia Bio (GaBio) congratulates Muna Oli Read More
3/8/2010
(Alpharetta, GA, March 8, 2010)--Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has completed a $20 million Series B financing round. New investor SonoSite, Inc. joined existing investor... Read More
3/5/2010
Atlanta, GA (March 5, 2010): NeurOp Corporation today announced that George (Barney) W. Koszalka has joined the company as President and CEO. As CEO, Dr. Koszalka will lead the company in a new growth phase to advance the company’s novel and proprietary small molecules directed against t... Read More
3/4/2010
By Dan Chapman
The Atlanta Journal-Constitution
9:49 a.m. Thursday, March 4, 2010
Last May, the state spent nearly $2 million hosting the biotech industry’s biggest annual convention at the Georgia World Congress Center. Billed as the debutante ball for the state... Read More
3/4/2010
For many, it may look as if the economic expansion of the late 1990s and the early 2000s might have missed the AUCC area. A great deal is happening. Both Ralph David Abernathy, Blvd. and MLK, Jr. Dr. have had significant facelifts. In addition to the facelifts, what the AUCC area n... Read More
3/2/2010
The Board of Regents of the University System of Georgia today named Dr. Ricardo Azziz, a physician/scientist/executive with more than 20 years of leadership in biomedical research, medical education and health care, as the eighth president of the Medical College of Georgia (MCG), Georgia’s health s... Read More
3/2/2010
Osaka (March 2, 2010) — Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) and QuatRx Pharmaceuticals Company (Head Office: Ann Arbor, MI, USA; CEO: Robert L. Zerbe M.D.; hereafter “QuatRx”) a privately-held pharmaceutical company, today a... Read More
3/1/2010
ATLANTA – March 1, 2010 – GeoVax Labs, Inc. (OTC BB: GOVX) (the “Company”), an Atlanta-based, biopharmaceutical company, today announced that it intends to file a registration statement for the sale of $20.0 million or more of its common stock. The offering may also include shares t... Read More
3/1/2010
ATLANTA, GA, March 1, 2010 – GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based biotechnology company focused on development of HIV/AIDS vaccines, today announced its financial results for the fourth quarter and year ended December 31, 2009.
GeoVax reported a net loss... Read More
2/28/2010
Aderans Research Institute Inc. (ARI) recently achieved a significant milestone in its Phase 2 clinical study of cell-based hair regeneration, treating the trial’s 100th subject. With clinical sites expected to double in the coming months, the study will likely add dozens of additional subjects ... Read More
2/26/2010
ATLANTA—February 26, 2010—Despite an ailing economy and sluggish job market, a new life sciences recruiting firm has emerged and is creating opportunities for companies and job seekers serving the industry.
Advanced Recruiting Partners (ARP) is one of a few Atlanta-b... Read More
2/25/2010
ATLANTA, GA (Feb. 25, 2010) – Nine high school students from five states will compete Monday, March 8, in the Southeastern regional finals of the 2010 sanofi-aventis International BioGENEius Challenge. The competition, conducted by the Biotechnology Institute, recognizes high school... Read More
2/23/2010
ATLANTA--(BUSINESS WIRE)--Georgia Governor Sonny Perdue announced today that QualTex Laboratories, a San Antonio, Texas-based independent blood testing lab, is expanding operations to Norcross, Georgia in Gwinnett County. The lab’s expansion in Georgia will create 125 high-skilled j... Read More
2/18/2010
ATLANTA – February 18, 2010 - GeoVax Labs, Inc. (OTC BB: GOVX) (the “Company”), an Atlanta-based, biopharmaceutical company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus), today announced that it presented the results of a preclinical study on a prot... Read More
2/18/2010
(February 18, 2010) The Cobb Workforce Investment board is learning first hand how South Cobb High School is implementing the Innovation Crescent bioscience program, which is a partnership of Georgia Bio and several other organizations that have come together in an effort to accelerate development o... Read More
2/16/2010
Abbott Park, Illinois (NYSE: ABT) — Abbott today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisition of Belgium-based Solvay Pharmaceuticals, providing Abbott with a large and complementary portfolio of pharmaceutical products and expanding Abbott's presen... Read More
2/15/2010
Board of Regents Chair Robert F. Hatcher and University System of Georgia Chancellor Erroll B. Davis Jr. have announced the name of the finalist for the presidency of the Medical College of Georgia (MCG) in Augusta – Dr. Ricardo Azziz, a physician/scientist/executive with more than 20 years of leade... Read More
2/11/2010
ATLANTA— The U.S. Department of Veterans Affairs (VA) has renewed the appointment of Yerkes National Primate Research Center Director Stuart Zola, PhD, as senior research career scientist (SRCS). The seven-year appointment, the highest honor the VA bestows on a PhD scientist, provides continuing sup... Read More
2/8/2010
ATLANTA – February 8, 2010 - GeoVax Labs, Inc. (OTC BB: GOVX)Read More
2/2/2010
ATLANTA, GA – February 2, 2010 - GeoVax Labs, Inc. (OTC BB: GOVX) (the ... Read More
1/30/2010
ATLANTA - Augusta Chronicle--- Other states are aggressively recruiting Georgia biotech startups, and cutting funding for a state business incubator could shoo them away before they grow enough for taxpayers to recover the investment made to nurture them, officials warned a Ho... Read More
1/28/2010
ANDOVER, Mass.--(BUSINESS WIRE)--Formatech continues its pledge to give back and make a difference in the biotechnology and pharmaceutical community with its Fillanthropy Program. Since the program’s inception, Formatech has donated $308K in aseptic liquid fill and finish manufacturing services to c... Read More
1/20/2010
Scientists at the Emory Institute for Drug Discovery will partner with GlaxoSmithKline (GSK) and Alnylam Pharmaceuticals on research aimed at developing new drugs for neglected tropical diseases in least developed countries.
Emory University has signed a Memorandum of Understanding wi... Read More
1/13/2010
ATLANTA, GA (January 13, 2010) - Sapna Hornyak, Director for Eastern U.S. Business Operations with Clinimetrics Research Associates, Inc., ha... Read More
1/13/2010
ATLANTA, GA (January 13, 2010) -- Georgia Bio (GaBio) each year recognizes individuals, companies or institutions for significant contributions... Read More
1/13/2010
ATLANTA--(BUSINESS WIRE)--Altea Therapeutics Corporation (“Altea”) announced today that it has entered into a partnership with KAI Pharmaceuticals, Inc. (“KAI”), a drug discovery and development company, for the preclinical and clinical ... Read More
1/12/2010
Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) today announced that its U.S.-based group company, Sciele Pharma, Inc. (hereafter “Sciele”), and two group companies have changed their company names as d... Read More
1/12/2010
ATLANTA, GA (January 6, 2010) – Solvay Pharmaceuticals, Inc. President Stephen Hill has been named Chair of the Georgia Bio Board of Directors and Aerovectrx CEO Thomas Callaway has been named Vice Chair.
Stephen Hill, BM, BCh, MA, FRCS, and Thomas Callaway, M.D., MBA, a... Read More
1/6/2010
ATLANTA – January 6, 2010 – GeoVax Labs, Inc. (OTC BB: GOVX) (the “Company”), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced the appointment of Mark J. ... Read More
12/21/2009
ATLANTA, GA (December 21, 2009) -- Georgia Bio (GaBio) announces that Senator David Adelman (D-42nd District) of Atlanta and Representative Am... Read More
12/21/2009
ATLANTA, GA (December 21, 2009) -- Georgia Bio (GaBio) announced its 2010 Deals of the Year for medical device and biopharmaceutical companies in four ... Read More
12/18/2009
ATLANTA, GA (December 18, 2009) – Louis W. Sullivan, M.D., President Emeritus of Morehouse School of Medicine and former U.S. Secretary of Health and Human Services, and John P. Richard, Managing Director of Georgia Venture Partners, are the recipients of the 2010 Georgi... Read More
12/17/2009
More than 300 people attended the Eleventh Annual Southeastern BIO Investor Forum on December 3-4th in Charleston, South Carolina. The Forum is the Southeast’s premier life sciences venture capital conference. SEBIO’s Investor Forum celebrated the growth of the life sciences industry in t... Read More
12/9/2009
ATLANTA, GA — December 9, 2009 – Celtaxsys, Inc., a privately held biopharmaceutical company focused on novel mechanisms of inflammation therapy, announced that it has hired Eric B. Springman, Ph.D. to the position of Chief Scientific Officer. In this new role, Dr. Springman will... Read More
12/8/2009
ATLANTA (November 16, 2009) — Sciele Pharma, Inc. (Head Office: Atlanta, Georgia, USA; President and CEO: Patrick P. Fourteau; hereafter “Sciele”), a U.S.-based group company of Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) and Add... Read More
12/1/2009
ATLANTA – December 1, 2009 - GeoVax Labs, Inc. (OTC BB: GOVX) (the “Company”), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its support for World AIDS Da... Read More
11/24/2009
Atlanta, GA (November 24, 2009) - Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast's life sciences industry, announced the selection of four fi... Read More
11/18/2009
Study shows capuchins have the ability to imitate others, a basis for the transmission of cultural behavior ATLANTA, GA - Researchers at the Yerkes National Primate Research Center, Emory University, an... Read More
11/16/2009
ATLANTA, GA (November 16, 2009) – Georgia Bio’s 2nd Annual Life Sciences Workforce Forum will feature an opening keynote address from Dr. Bruce Fuchs, ... Read More
11/10/2009
Atlanta, GA (November 10, 2009) – Georgia Bio, Piedmont Healthcare and other organizatio... Read More
10/29/2009
ATLANTA-- (BUSINESS WIRE) -- Inhibitex, Inc. (Nasdaq: INHX) today reported the completion of its previously announced $23 million private placement of common stock and warrants. Investors in the private placement purchased units, each consisting of one share of common stock and a wa... Read More
10/27/2009
October ... Read More
10/26/2009
ATLANTA - Veteran biosciences entrepreneur Nina Sawczuk has joined Georgia Tech’s Advanced Technology Development Center (ATDC) as assistant director for biosciences. In this role, she will support the commercialization of bioscience innovation throughout t... Read More
10/23/2009
Inhibitex, Inc. (Nasdaq: INHX) today announced that it has entered into definitive purchase agreements with institutional investors for the sale of approximately $23 million of its common stock, and warrants to purchase common stock, in a private placement. The private placement was led by QVT fu... Read More
10/2/2009
WASHINGTON, DC (October 2, 2009) – An amendment offered by Senator Robert Menendez (D-NJ) was adopted by the Senate Finance Committee early this morning that would create a tax credit to encourage investments in new breakthrough medical therapies to prevent, diagnose, and treat a... Read More
RSS 
Members may submit a press release for posting by emailing it to
maria.thacker@gabio.org.